Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-014-1 | CAS number: 1072-71-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- January 2000 - March 2007
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was not conducted according to GLP and test guidelines. It does not contain sufficient amount of data for the interpretation of the results as the method is not described in detail.
Data source
Reference
- Reference Type:
- publication
- Title:
- Contact allergy to 2,5-dimercapto-1,3,4-thiadiazole and phenyl-α-naphtylamine, allergens in industrial greases and lubricant oils – contact allergy to water-insoluble greases is uncommon but needs to be considered in some workers
- Author:
- Finnish Institue of Occupational Health (FIOH), Control of Hypersensitivity Diseases and Occupational Medicine, Helsinki, Finland
- Year:
- 2 008
- Bibliographic source:
- Contact Dermatitis 2008: 58: 93-96
Materials and methods
- Type of sensitisation studied:
- skin
- Study type:
- case report
- Principles of method if other than guideline:
- Patch test was performed using the Finn Chambers on Scanpore tape (Epitest, Tuusula, Finland). The following allergens in greases and lubricants were tested:2,5-dimercapto-1,3,4-thiadiazole, phenyl-α-naphtylamine, tertiary butyl hydroquinone, EHZDTP, coconut diethanolamide and dipentene.
- GLP compliance:
- not specified
- Remarks:
- not applicable
Test material
- Reference substance name:
- 1,3,4-thiadiazole-2,5-dithiol
- EC Number:
- 214-014-1
- EC Name:
- 1,3,4-thiadiazole-2,5-dithiol
- Cas Number:
- 1072-71-5
- Molecular formula:
- C2H2N2S3
- IUPAC Name:
- 1,3,4-thiadiazole-2,5-dithiol
- Details on test material:
- Product number: CAS No: 1072-71-5; 1,3,4-Thiadiazole-2,5-dithiol
Description: aromatic compound in oils and greases
Constituent 1
Method
- Type of population:
- occupational
- Ethical approval:
- not specified
- Subjects:
- - Number of cases: 2 out of 112 patients
- Sex: Male
- Age: 50-52
- Race: Not Designated
Patient 1 was a 50-year-old male computer numerical control machinist who had previously had occasional skin symptoms on various parts of his body, including foot dermatitis while using protection shoes. In 1999 he developed hand dermatitis for the first time, and it healed during sick leaves.
Patient 2 was a 52-year-old male lorry assembler who developed work-related eczema on his eyelids and around his eyes in 2003. - Route of administration:
- dermal
- Details on study design:
- TYPE OF TEST USED: patch test (epicutaneous test)
ADMINISTRATION
- Type of application: epicutaneous
- Description of patch: Finn Chambers on Scanpore tape
- Concentration: Patient 1: guide-way oil at 20%, first time: 2,5-Dimercapto-1,3,4-thiadiazole 20%, 10%, 3.2% and 1%,
second time: 2,5-Dimercapto-1,3,4-thiadiazole 2%, 1%, 0.32% and 0.1%
Patient 2: first time: 2,5-dimercapto-1,3,4-thiadiazole 1 %, second time: with the dilution series of the centre grease: 100–3.2% concentrations and 1% , 3rd time: 2,5-dimercapto-1,3,4-thiadiazole derivative 2–0.06%, and 2,5-dimercapto-1,3,4-thiadiazole dimer 2–0.06%
(lower concentrations were not tested).
EXAMINATIONS
- Grading/Scoring system: - No reaction / ? Doubtful response, barely perceptible erythema / + Definite erythema, No edema / ++ Definite erythema, Definite edema / +++ Definite erythema, Definite edema & vesiculation
Results and discussion
- Results of examinations:
- NO. OF PERSONS WITH/OUT ALLERGIC REACTIONS:
- Number of subjects with positive reactions: 2
- Number of subjects with negative reactions: 110
Applicant's summary and conclusion
- Conclusions:
- Based on this case study it can be assumed that 1,3,4-Thiadiazole-2,5-dithiol possesses low potential to induce dermal sensitisation in human subjects.
- Executive summary:
Patient 1: In 2001, in patch testing he reacted to guide-way oil at 20% (+?). 8 months later 3 components of the guide-way oil were tested, and the patient had an allergic reaction to 1 component of the guide-way oil, dimercaptothiadiazole (DMTD; trade name Oloa 4452X): 20% +, 10% ?+, 3.2% ?+, 1% ?+. 4 months later 2,5-Dimercapto-1,3,4-thiadiazole was tested for the second time: 2% +, 1%, 0.32%, and 0.1% mild follicular reaction (?+). 18 control patients were negative to 2% 2,5-dimercapto-1,3,4-thiadiazole.
Patient 2: In 2005 on patch testing he reacted to his centre lubrication grease (as such; ++) and 2,5-dimercapto-1,3,4- thiadiazole (1%, ++). 6 moths later, after many inquiries, the manufacturer of the centre grease informed us that it contained 0.25% 2,5-dimercapto- 1,3,4-thiadiazole (CAS 1072-71-5) derivative and 0.25% 5,5-dithiobis(1,3,4-thiadiazole-2(3H)-thione (CAS 72676-55-2; 2,5-dimercapto-1,3,4-thiadiazole dimer). In the meanwhile, we had tested the patient for the second time with the dilution series of the centre grease: 100–3.2% concentrations gave ++ reactions, and 1% gave a + reaction. 5 control patients were negative to 100% and 10% centre grease. On the 3rd patch test session he had strong allergic reactions (++) to the 2,5- dimercapto-1,3,4-thiadiazole derivative 2–0.06%, and to 2,5-dimercapto-1,3,4-thiadiazole dimer 2–0.06% (lower concentrations were not tested).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
